Ann: Dispute with Solagran Limited , page-15

If it is that simple, it makes me feel a lot better. Basically BPO (based on one experienced patent attorney) wants to challenge SLA's IP over Bioeffectives.

For what its worth... its a very long shot. And screams 'desperation' if that is indeed what they are going for.

I mean they already had a chance to look at the patents during DD and signed off on those... Goodluck to BPO if that is the case. They'll need it!